IL93243A - Preparations for the prevention of neurodegeneration - Google Patents

Preparations for the prevention of neurodegeneration

Info

Publication number
IL93243A
IL93243A IL9324390A IL9324390A IL93243A IL 93243 A IL93243 A IL 93243A IL 9324390 A IL9324390 A IL 9324390A IL 9324390 A IL9324390 A IL 9324390A IL 93243 A IL93243 A IL 93243A
Authority
IL
Israel
Prior art keywords
neurodegeneration
treatment
prevention
connection
chloroethyl
Prior art date
Application number
IL9324390A
Other languages
English (en)
Hebrew (he)
Other versions
IL93243A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL93243A0 publication Critical patent/IL93243A0/xx
Publication of IL93243A publication Critical patent/IL93243A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9324390A 1989-02-17 1990-02-01 Preparations for the prevention of neurodegeneration IL93243A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900564A SE8900564D0 (sv) 1989-02-17 1989-02-17 Novel medicinal use

Publications (2)

Publication Number Publication Date
IL93243A0 IL93243A0 (en) 1990-11-29
IL93243A true IL93243A (en) 1994-08-26

Family

ID=20375091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9324390A IL93243A (en) 1989-02-17 1990-02-01 Preparations for the prevention of neurodegeneration

Country Status (16)

Country Link
EP (1) EP0458892B1 (da)
JP (1) JP3007683B2 (da)
KR (1) KR0139221B1 (da)
AT (1) ATE107166T1 (da)
AU (1) AU643431B2 (da)
CA (1) CA2045618A1 (da)
DE (1) DE69009989T2 (da)
DK (1) DK0458892T3 (da)
ES (1) ES2055421T3 (da)
HK (1) HK44597A (da)
IE (1) IE64622B1 (da)
IL (1) IL93243A (da)
NZ (1) NZ232499A (da)
PH (1) PH26372A (da)
SE (1) SE8900564D0 (da)
WO (1) WO1990009174A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS1688B (is) * 1991-10-30 1998-04-20 Ab Astra Ný aðferð við framleiðslu 4-metýl-5-(2-klóróetýl)-þíasól og hliðstæðum þess og ný milliefni við framleiðslu efnasambandanna
SE9802119D0 (sv) * 1998-06-15 1998-06-15 Astra Ab New use
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE196140C1 (da) * 1964-01-01

Also Published As

Publication number Publication date
DE69009989T2 (de) 1994-10-13
SE8900564D0 (sv) 1989-02-17
IE64622B1 (en) 1995-08-23
AU5167990A (en) 1990-09-05
AU643431B2 (en) 1993-11-18
IE900460L (en) 1990-08-17
DE69009989D1 (de) 1994-07-21
EP0458892A1 (en) 1991-12-04
ATE107166T1 (de) 1994-07-15
ES2055421T3 (es) 1994-08-16
KR920700641A (ko) 1992-08-10
WO1990009174A1 (en) 1990-08-23
PH26372A (en) 1992-06-01
NZ232499A (en) 1992-12-23
CA2045618A1 (en) 1990-08-18
KR0139221B1 (en) 1998-05-15
IL93243A0 (en) 1990-11-29
JP3007683B2 (ja) 2000-02-07
EP0458892B1 (en) 1994-06-15
DK0458892T3 (da) 1994-08-15
HK44597A (en) 1997-04-18

Similar Documents

Publication Publication Date Title
DE69100282T2 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DE69713890T3 (de) Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin-sensitivität erhöht
SK2922002A3 (en) Use of retigabin for treating neuropathic pain
JPS5910585A (ja) スピロスクシンイミド誘導体のアルツハイマ−型痴「ほう」の治療における使用
EP0458892B1 (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
JPH0320222A (ja) 脳内虚血症治療剤
CA2554082C (en) Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
US5399572A (en) Chlormethiazole in the treatment of neurodegeneration
CZ285633B6 (cs) Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek
HUT50440A (en) Process for producing pharmaceutical compositions for treating schizophrenia
EP1121110B1 (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
JP2549480B2 (ja) 排尿障害改善剤
EP1410808A1 (en) Optic nerve protecting agents containing alpha 1 receptor blocker as the active ingredient
CZ287441B6 (en) Pharmaceutical preparation for treating traumatic lesion of brain
KR20230043905A (ko) 5-메틸-1,2,4-옥사디아졸-3-일 화합물의 저용량 요법 및 제제
JPH04503512A (ja) 新規な医薬用途
ES2281775T3 (es) Metodo para tratar insuficiencia renal.
AU2017305661B2 (en) New use of N,N-bis-2-mercaptoethyl isophthalamide
JPH07507280A (ja) (−)−メトリフォネート含有薬剤
JPH0251885B2 (da)
US9192602B2 (en) Indication of anthra[2,1,c][1,2,5]thiadiazole-6,11-dione compound in alleviating pain
CN1200710C (zh) 大环内酯类化合物的新用途
AU8409291A (en) 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole
US9284281B2 (en) Indication of naphtho[2,3-F]quinoxaline-7,12-dione compound in alleviating pain
Midtvedt Penicillins, cephalosporins and tetracyclines

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
FF Patent granted
RH1 Patent not in force